Copyright Reports & Markets. All rights reserved.

Global Pharmaceutical Contract Development and Manufacturing Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Pharmaceutical Contract Development and Manufacturing Market Overview

    • 1.1 Product Overview and Scope of Pharmaceutical Contract Development and Manufacturing
    • 1.2 Classification of Pharmaceutical Contract Development and Manufacturing by Types
      • 1.2.1 Global Pharmaceutical Contract Development and Manufacturing Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Types in 2018
      • 1.2.3 Pharmaceutical Manufacturing Services
      • 1.2.4 Biologics Manufacturing Services
      • 1.2.5 Drug Development Services
    • 1.3 Global Pharmaceutical Contract Development and Manufacturing Market by Application
      • 1.3.1 Global Pharmaceutical Contract Development and Manufacturing Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Big Pharma
      • 1.3.3 Small Pharma
      • 1.3.4 Generic Pharma
      • 1.3.5 CRO
    • 1.4 Global Pharmaceutical Contract Development and Manufacturing Market by Regions
      • 1.4.1 Global Pharmaceutical Contract Development and Manufacturing Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Pharmaceutical Contract Development and Manufacturing Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Pharmaceutical Contract Development and Manufacturing Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pharmaceutical Contract Development and Manufacturing Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Pharmaceutical Contract Development and Manufacturing Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pharmaceutical Contract Development and Manufacturing Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Pharmaceutical Contract Development and Manufacturing (2014-2024)

    2 Company Profiles

    • 2.1 AbbVie Inc.
      • 2.1.1 Business Overview
      • 2.1.2 Pharmaceutical Contract Development and Manufacturing Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Aenova Group
      • 2.2.1 Business Overview
      • 2.2.2 Pharmaceutical Contract Development and Manufacturing Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Recipharm AB
      • 2.3.1 Business Overview
      • 2.3.2 Pharmaceutical Contract Development and Manufacturing Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Recipharm AB Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Catalent, Inc.
      • 2.4.1 Business Overview
      • 2.4.2 Pharmaceutical Contract Development and Manufacturing Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Thermo Fisher Scientific Inc.
      • 2.5.1 Business Overview
      • 2.5.2 Pharmaceutical Contract Development and Manufacturing Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Lonza Group Ltd
      • 2.6.1 Business Overview
      • 2.6.2 Pharmaceutical Contract Development and Manufacturing Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Almac Group
      • 2.7.1 Business Overview
      • 2.7.2 Pharmaceutical Contract Development and Manufacturing Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Almac Group Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 FAMAR Health Care Services
      • 2.8.1 Business Overview
      • 2.8.2 Pharmaceutical Contract Development and Manufacturing Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Vetter Pharma International GMBH
      • 2.9.1 Business Overview
      • 2.9.2 Pharmaceutical Contract Development and Manufacturing Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Consort Medical plc
      • 2.10.1 Business Overview
      • 2.10.2 Pharmaceutical Contract Development and Manufacturing Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Siegfried Holding AG
      • 2.11.1 Business Overview
      • 2.11.2 Pharmaceutical Contract Development and Manufacturing Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Boehringer Ingelheim International GmbH
      • 2.12.1 Business Overview
      • 2.12.2 Pharmaceutical Contract Development and Manufacturing Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Evonik Industries AG
      • 2.13.1 Business Overview
      • 2.13.2 Pharmaceutical Contract Development and Manufacturing Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Pharmaceutical Contract Development and Manufacturing Market Competition, by Players

    • 3.1 Global Pharmaceutical Contract Development and Manufacturing Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Pharmaceutical Contract Development and Manufacturing Players Market Share
      • 3.2.2 Top 10 Pharmaceutical Contract Development and Manufacturing Players Market Share
    • 3.3 Market Competition Trend

    4 Global Pharmaceutical Contract Development and Manufacturing Market Size by Regions

    • 4.1 Global Pharmaceutical Contract Development and Manufacturing Revenue and Market Share by Regions
    • 4.2 North America Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)
    • 4.5 South America Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)

    5 North America Pharmaceutical Contract Development and Manufacturing Revenue by Countries

    • 5.1 North America Pharmaceutical Contract Development and Manufacturing Revenue by Countries (2014-2019)
    • 5.2 USA Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)

    6 Europe Pharmaceutical Contract Development and Manufacturing Revenue by Countries

    • 6.1 Europe Pharmaceutical Contract Development and Manufacturing Revenue by Countries (2014-2019)
    • 6.2 Germany Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)
    • 6.3 UK Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)
    • 6.4 France Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Revenue by Countries

    • 7.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Revenue by Countries (2014-2019)
    • 7.2 China Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)
    • 7.5 India Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)

    8 South America Pharmaceutical Contract Development and Manufacturing Revenue by Countries

    • 8.1 South America Pharmaceutical Contract Development and Manufacturing Revenue by Countries (2014-2019)
    • 8.2 Brazil Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Pharmaceutical Contract Development and Manufacturing by Countries

    • 9.1 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Pharmaceutical Contract Development and Manufacturing Revenue and Growth Rate (2014-2019)

    10 Global Pharmaceutical Contract Development and Manufacturing Market Segment by Type

    • 10.1 Global Pharmaceutical Contract Development and Manufacturing Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Pharmaceutical Contract Development and Manufacturing Market Forecast by Type (2019-2024)
    • 10.3 Pharmaceutical Manufacturing Services Revenue Growth Rate (2014-2024)
    • 10.4 Biologics Manufacturing Services Revenue Growth Rate (2014-2024)
    • 10.5 Drug Development Services Revenue Growth Rate (2014-2024)

    11 Global Pharmaceutical Contract Development and Manufacturing Market Segment by Application

    • 11.1 Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Application (2014-2019)
    • 11.2 Pharmaceutical Contract Development and Manufacturing Market Forecast by Application (2019-2024)
    • 11.3 Big Pharma Revenue Growth (2014-2019)
    • 11.4 Small Pharma Revenue Growth (2014-2019)
    • 11.5 Generic Pharma Revenue Growth (2014-2019)
    • 11.6 CRO Revenue Growth (2014-2019)

    12 Global Pharmaceutical Contract Development and Manufacturing Market Size Forecast (2019-2024)

    • 12.1 Global Pharmaceutical Contract Development and Manufacturing Market Size Forecast (2019-2024)
    • 12.2 Global Pharmaceutical Contract Development and Manufacturing Market Forecast by Regions (2019-2024)
    • 12.3 North America Pharmaceutical Contract Development and Manufacturing Revenue Market Forecast (2019-2024)
    • 12.4 Europe Pharmaceutical Contract Development and Manufacturing Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Revenue Market Forecast (2019-2024)
    • 12.6 South America Pharmaceutical Contract Development and Manufacturing Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Scope of the Report:
      The global Pharmaceutical Contract Development and Manufacturing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Pharmaceutical Contract Development and Manufacturing.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Pharmaceutical Contract Development and Manufacturing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Pharmaceutical Contract Development and Manufacturing market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      AbbVie Inc.
      Aenova Group
      Recipharm AB
      Catalent, Inc.
      Thermo Fisher Scientific Inc.
      Lonza Group Ltd
      Almac Group
      FAMAR Health Care Services
      Vetter Pharma International GMBH
      Consort Medical plc
      Siegfried Holding AG
      Boehringer Ingelheim International GmbH 
      Evonik Industries AG

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Pharmaceutical Manufacturing Services
      Biologics Manufacturing Services
      Drug Development Services

      Market Segment by Applications, can be divided into
      Big Pharma
      Small Pharma
      Generic Pharma
      CRO
      Buy now